- Home
- BCBP vs EDIT Comparison
BCBP vs EDIT Comparison
Compare BCBP & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- EDIT
- Stock Information
- Founded
- BCBP 2000
- EDIT 2013
- Country
- BCBP United States
- EDIT United States
- Employees
- BCBP N/A
- EDIT N/A
- Industry
- BCBP Savings Institutions
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCBP Finance
- EDIT Health Care
- Exchange
- BCBP Nasdaq
- EDIT Nasdaq
- Market Cap
- BCBP 143.5M
- EDIT 156.5M
- IPO Year
- BCBP N/A
- EDIT 2016
- Fundamental
- Price
- BCBP $7.84
- EDIT $2.25
- Analyst Decision
- BCBP Hold
- EDIT Buy
- Analyst Count
- BCBP 2
- EDIT 13
- Target Price
- BCBP $11.75
- EDIT $6.73
- AVG Volume (30 Days)
- BCBP 79.2K
- EDIT 2.4M
- Earning Date
- BCBP 07-18-2025
- EDIT 08-06-2025
- Dividend Yield
- BCBP 8.17%
- EDIT N/A
- EPS Growth
- BCBP N/A
- EDIT N/A
- EPS
- BCBP 0.15
- EDIT N/A
- Revenue
- BCBP $63,178,000.00
- EDIT $35,837,000.00
- Revenue This Year
- BCBP $22.41
- EDIT N/A
- Revenue Next Year
- BCBP $10.90
- EDIT N/A
- P/E Ratio
- BCBP $52.37
- EDIT N/A
- Revenue Growth
- BCBP N/A
- EDIT N/A
- 52 Week Low
- BCBP $7.54
- EDIT $0.91
- 52 Week High
- BCBP $14.04
- EDIT $6.05
- Technical
- Relative Strength Index (RSI)
- BCBP 42.67
- EDIT 63.76
- Support Level
- BCBP $7.67
- EDIT $2.05
- Resistance Level
- BCBP $7.89
- EDIT $2.55
- Average True Range (ATR)
- BCBP 0.21
- EDIT 0.23
- MACD
- BCBP 0.02
- EDIT 0.03
- Stochastic Oscillator
- BCBP 46.15
- EDIT 66.29
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.